SHS backs AOT

SHS cited the growing market for robot-guided surgical systems as a reason to invest. It will back the market launch of AOT's surgery system Carlo (computer assisted robot-guided laser osteotome).

SHS invested via its fourth fund, which held a first close on €56m in January 2014. The fund has a target of €100m. SHS IV has the same investment focus as previous SHS vehicles, that is, minority and majority stakes in medical technology and life sciences companies.

The fund already holds a medical technology portfolio company having backed laser catheter manufacturer Vimecon in December 2014. SHS stated further life sciences investments are planned for 2015.

Company
Founded in 2011 as a spin-off from the Basel University Hospital, AOT develops, produces and markets computer-assisted laser systems for use in bone surgery.

People
Bernhard Schirmers is managing partner at SHS. Alfred Bruno is CEO and co-founder of AOT.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• Switzerland